Order Center
 
Product Catalog →  Cell Biology →  Cell Signaling and Neuroscience →  Neuroscience →  Neurotransmission →  Neurotransmitters →  Biogenic Amine Transport Inhibitors
 Print Preview
Visit the Cell Biology Center     Discover Peptides and Proteins!

Biogenic Amine Transport Inhibitors

Mechanism of Action of Selective Monoaminergic Reuptake Inhibitors. During neurotransmission, monoamine neurotransmitters such as serotonin, dopamine or norepinephrine, are released into the synaptic cleft from storage vesicles present in the pre-synaptic neuron (A). The neurotransmitters then bind to their respective receptors on the post-synaptic neuron, thereby transferring the signal. The actions of the neurotransmitters are terminated via their reuptake into the pre-synaptic neuron via specific transporter proteins following which the neurotransmitter is taken up into the vesicles for re-release. When a monoaminergic reuptake inhibitor is present (B), it binds to the monoamine transporter and blocks the reuptake of the neurotransmitter whose levels increase in the synaptic cleft thereby enhancing neurotransmission.



Image
Description
Biochem/physiol Actions
CAS Number
Product #
(−)-2β-Carbomethoxy-3β-(4-iodophenyl)nortropane crystalline 5-HT serotonin transporter inhibitor; precursor of [123I]nor-β-CIT, a radioligand for SPECT imaging of the 5-HT transporter.
136794-87-1 C155
(R)-Tomoxetine hydrochloride solid Norepinephrine uptake blocker.
82248-59-7 T7947
6-Nitroquipazine maleate salt solid Potent and selective serotonin transport blocker.
77372-73-7 Q109
Alaproclate hydrochloride Potent and selective serotonin uptake inhibitor.
60719-83-7 A164
Amitriptyline hydrochloride ≥98% (TLC), powder Tricyclic antidepressant; inhibits the norepinephrine and serotonin transporters with Kis of 100 nM and 14.7 nM, respectively; high in vitro affinity for α1-adrenoceptors, serotonin and muscarinic acetylcholine receptors.
549-18-8 A8404
Amoxapine Tricyclic antidepressant; inhibits uptake of norepinephrine; inhibits 5-HT2 serotonergic receptors.
14028-44-5 A129
BTCP hydrochloride solid Potent and selective blocker of dopamine transport with little affinity for phencyclidine sites.
112726-66-6 B138
Bupropion hydrochloride ≥98% (HPLC), solid Inhibits the dopamine and norepinephrine transporters with Kis of 2.8 μM and 1.4 μM, respectively. Does not inhibit the serotonin transporter (Ki = 45 μM). Antidepressant.
31677-93-7 B102
Citalopram hydrobromide solid Potent and selective serotonin uptake inhibitor (Ki = 5.4 nM); antidepressant
59729-32-7 C7861
Clomipramine hydrochloride ≥98% (HPLC), powder Tricyclic antidepressant; inhibits serotonin and norepinephrine transporters.
17321-77-6 C7291
Desipramine hydrochloride ≥98% (TLC), powder Tricyclic antidepressant that is a more potent inhibitor of the norepinephrine transporter (Ki = 4 nM) than the serotonin transporter (Ki = 61 nM).
58-28-6 D3900
Desvenlafaxine hydrochloride ≥98% (HPLC), solid Desvenlafaxine hydrochloride is a dual SERT/NET reuptake inhibitor. It is a major active metabolite of venlafaxine (#542); brain penetrant; Ki = 40 nM and 122 nM for hSERT and hNET, respectively (weak binding at the hDAT). Inhibition of [3H]5-HT or [3H]NE uptake for the hSERT or hNET produced IC50 values of 47 and 531 nM.
300827-87-6 D2069
Doxepin hydrochloride ~85% E-isomer basis, ≥98% (GC), 15% Z-isomer basis, powder Tricyclic antidepressant that is a more potent inhibitor of norepinephrine uptake than of serotonin uptake; antagonist at H1 histamine, muscarinic cholinergic, and α-adrenoreceptors.
1229-29-4 D4526
Fluoxetine hydrochloride solid Selective serotonin reuptake inhibitor; antidepressant.
56296-78-7 F132
Fluvoxamine maleate solid Selective serotonin reuptake inhibitor; antidepressant.
61718-82-9 F2802
GBR 12909 dihydrochloride solid, ≥98% (HPLC) Highly selective dopamine reuptake inhibitor with behavioral effects similar to cocaine.
67469-78-7 D052
GBR 12935 dihydrochloride ≥98% (TLC), powder Inhibits the dopamine and norepinephrine transporters with Kis of 21.5 nM and 225 nM, respectively. Does not inhibit the serotonin transporter (Ki = 6.5 μM). Binds to a nondopaminergic piperazine site in blood platelets and brain that has been identified as cytochrome P450.
67469-81-2 G9659
GYKI 52895 solid Selective dopamine uptake inhibitor; antiparkinsonian; antidepressant.
G120
Imipramine hydrochloride ≥99% (TLC), crystalline Tricyclic antidepressant; inhibits the serotonin and norepinephrine transporters with Kis of 7.7 nM and 67 nM, respectively. Has little effect on the dopamine transporter (Ki = 25 μM).
113-52-0 I7379
Indatraline hydrochloride solid Potent inhibitor of dopamine, norepinephrine and serotonin uptake.
96850-13-4 I119
Lofepramine hydrochloride ≥98% (HPLC), solid Lofepramine is an antidepressant; serotonin and norepinephrine re-uptake inhibitor (SNRI).
26786-32-3 L8792
Maprotiline hydrochloride >99% (HPLC), powder Selective norepinephrine uptake inhibitor.
10347-81-6 M9651
Mazindol ≥98% (TLC), powder Anorectic agent; inhibits the dopamine, norepinephrine and serotonin transporters with Kis of 27.6 nM, 3.2 nM, and 153 nM, respectively.
22232-71-9 M2017
Mirtazapine ≥98% (HPLC), solid Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA). Mirtazapineant agonizes selective adrenergic and serotonergic receptors so that both NE release and 5-HT1A mediated serotonergic signaling are increased.
61337-67-5 M0443
Nefazodone hydrochloride ≥98% (HPLC), solid Novel antidepressant; mixed 5-HT2A serotonin receptor antagonist/serotonin uptake inhibitor.
82752-99-6 N5536
Nisoxetine hydrochloride solid, ≥98% (HPLC) Potent and selective inhibitor of the norepinephrine transporter (Ki = 5.1 nM).
57754-86-6 N151
Nomifensine maleate salt Selective dopamine uptake inhibitor interacting with the dopamine transporter at a site different from that of cocaine; antidepressant.
32795-47-4 N1530
Norfluoxetine hydrochloride ≥97%, solid Fluoxetine metabolite; more potent inhibitor of serotonin uptake than fluoxetine with a half-life in vivo of 5-7 days.
83891-03-6 F133
Nortriptyline hydrochloride ≥98% (TLC), powder Tricyclic antidepressant that is a more potent inhibitor of the norepinephrine transporter (Ki = 3.4 nM) than the serotonin transporter (Ki = 161 nM). 5-HT2 serotonin receptor antagonist.
894-71-3 N7261
Paroxetine hydrochloride hemihydrate ≥98% (HPLC), solid Paroxetine hydrochloride hemihydrate is one of the most potent and selective of the selective serotonin reuptake inhibitors (SSRI); antidepressant
110429-35-1 P9623
Protriptyline hydrochloride ≥98% (TLC), powder Norepinephrine uptake blocker.
1225-55-4 P8813
R-(−)-Fluoxetine hydrochloride >98% (HPLC), solid Selective serotonin reuptake inhibitor.
114247-09-5 F1678
Reboxetine mesylate hydrate >96% (HPLC), solid Reboxetine mesylate hydrate is a selective noradrenaline uptake inhibitor.
98769-84-7 (anhydrous) R6527
S-(+)-Fluoxetine hydrochloride ≥98% (HPLC), solid Selective serotonin reuptake inhibitor.
114247-06-2 F1553
Sibutramine hydrochloride monohydrate ≥98% (HPLC), solid Sibutramine is a serotonin and noradrenaline reuptake inhibitor (SNRI). It is an antiobesity drug, which decreases calorie intake and increases energy expanditure. Sibutramine antagonizes MPTP-induced dopamine depletion in mouse brain.
125494-59-9 S9944
Tianeptine sodium salt solid Tricyclic antidepressant; enhances serotonin uptake.
30123-17-2 T1692
Trazodone hydrochloride >99% (HPLC), powder Antidepressant that potentiates the activity of serotonin uptake blockers and has full 5-HT2C serotonin receptor agonist activity. It is metabolized to the 5-HT1 serotonin receptor agonist 1-(3-Chlorophenyl)piperazine.
25332-39-2 T6154
Trimipramine maleate salt ≥98% (TLC), powder Antidepressant; serotonin transport blocker that also blocks norepinephrine uptake.
521-78-8 T3146
Venlafaxine hydrochloride ≥98% (HPLC), powder Venlafaxine is an antidepressant. The mechanism of the antidepresant action of venlafaxine in humans is associated with its potentiation of neurotransmitter activity in the CNS. Venlafaxine is a potent inhibitor of neuronal serotonin and norepinephrine reuptake and weak inhibitor of dopamine reuptake. Venlafaxine has no significant activity for muscarinic, histaminergic, or α-1 adrenergic receptors in vitro. Venlafaxine does not possess MAO inhibitor activity.
99300-78-4 V7264
Zimelidine dihydrochloride solid Serotonin transport blocker; antidepressant.
61129-30-4 Z101
β-CFT naphthalenedisulfonate monohydrate solid Cocaine analog that inhibits the dopamine, norepinephrine, and serotonin transporters with Kis of 26.1 nM, 31.9 nM, and 127 nM, respectively. [11C]-β-CFT and [18F]-β-CFT are ligands for PET imaging of the dopamine transporter in vivo.
77210-32-3 (anhydrous) C124

 Site Use Terms Terms and Conditions of Sale Privacy
Copyrights © 2008 Sigma-Aldrich Co. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc.